Larvol Delta - Coya-Therapeutics-Licenses-Intellectual-Property-Rights-for-Use-of-Next-Generation-Immune-Modulatory-Biologics-in-Combination-with-COYA-301-to-Enhance-Regulatory-T-Cells-Tregs-in-Inflammatory-Diseases

COYA 301 - Coya Therap

https://www.businesswire.com/news/home/20240213679651/en/Coya-Therapeutics-Licenses-Intellectual-Property-Rights-for-Use-of-Next-Generation-Immune-Modulatory-Biologics-in-Combination-with-COYA-301-to-Enhance-Regulatory-T-Cells-Tregs-in-Inflammatory-Diseases

Feb 13, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next